CAS 2250440-41-4

Formula: C43H60O6

InChI: InChI=1S/C43H60O6/c1-30(17-14-18-31(2)19-21-39-42(9,10)27-37(49-33(4)45)28-43(39,11)48)15-12-13-16-32(3)23-35(46)24-34(29-44)20-22-38-40(5,6)25-36(47)26-41(38,7)8/h12-24,29,36-38,47-48H,25-28H2,1-11H3/b15-12?,16-13?,18-14?,22-20+,30-17?,31-19?,32-23?,34-24-,39-21?/t36?,37-,38?,43-/m1/s1

InChI key: XZAPEHKCHWMSPW-MTALQEDYSA-N

SMILES: CC(=CC=CC(=CC=C1[C@](C[C@@H](CC1(C)C)OC(=O)C)(C)O)C)C=CC=CC(=CC(=O)/C=C(/C=C/C2C(CC(CC2(C)C)O)(C)C)\C=O)C

Vilobelimab

CAS: 2250440-41-4

Vilobelimab

Formula: C₄₃H₆₀O₆

Purity: 95%

Molecular weight: 672.93

Ref: 54-OR1162401

Vilobelimab

CAS: 2250440-41-4

Vilobelimab (CaCP-29, IFX-1), a monoclonal antibody, inhibits C5a to reduce inflammation and is researched in sepsis and COVID-19 studies.

Purity: 99% (SDS-PAGE); 98.9% (SEC-HPLC) - 99% (SDS-PAGE); 98.9% (SEC-HPLC)

Color and Shape: Transparent Liquid

Molecular weight: 145.86 kDa (Predicted)

Ref: TM-T76958

Vilobelimab

CAS: 2250440-41-4

Purity: 95%

Molecular weight: G/Mol

Ref: IN-DA027PP3